Areas of Expertise
The two main types are Hodgkin lymphoma and the more common non-Hodgkin lymphoma. Non-Hodgkin lymphoma can be indolent where treatment may not always be needed or aggressive, where tumor cells multiply and spread more rapidly, causing the patient to become very sick. In recent years, the prognosis of many sub-types of lymphoma has improved tremendously due to the introduction of novel targeted drugs and immunotherapy.
Multiple myeloma is a cancer of the bone marrow plasma cells. Unlike many cancers, multiple myeloma does not exist as a lump or tumour. It is confirmed by the demonstration of increased plasma cells in the bone marrow and a monoclonal protein band when the patients present with bone problems, kidney failure, high calcium levels or anaemia. Early treatment can be effective at controlling the disease, relieving its complications, and prolonging life. Standard treatment for multiple myeloma is evolving rapidly with the introduction of novel drugs and immunotherapy.
Chronic Lymphocytic Leukaemia
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. It’s a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Many patients do not have any symptoms for at least a few years. But over time, the cells grow in number and spread to other parts of the body, including the lymph nodes, liver, and spleen. Blood tests can be done for early detection. With advances in treatment, a chemo-free approach to CLL is now a reality.